6 May 2016 - Deborah Wilkes
Archived
Blackmores is gaining a foothold in the Chinese herbal medicines market by acquiring fellow Australian company Global Therapeutics, including its Fusion and Oriental Botanicals brands, for A$23 million (US$17 million).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.